BACKGROUND. Results from the Mayo Lung Project (MLP), a randomized clinical
trial for the early detection of lung carcinoma, were interpreted as proof
that the early detection of lung carcinoma by chest X-ray does not reduce
the mortality from this disease. Recent analysis of extended follow-up data
from the MLP subjects found that after approximately 20 years there still
was no apparent difference in lung carcinoma mortality between a study grou
p and a control group.
METHODS. To view this result within context, the authors utilized a previou
sly published simulation model of the MLP, with parametric values that were
estimated at the time of the original publication based on the data collec
ted by the MLP.
RESULTS. The model produced predictions of the extended follow-up statistic
s that were found to be consistent with the data published in the prior stu
dy. The authors believe this provides long-term validation for the model. C
onversely, the same model demonstrated that had the study subjects been scr
eened annually for the extended follow-up period, the difference in mortali
ty would be noticeable, even with the low sensitivity of chest X-ray detect
ion.
CONCLUSIONS. The results of current study strongly suggest that long-term s
creening with chest X-ray results in a reduction in lung carcinoma mortalit
y. The limited extent of this benefit is the result of the low sensitivity
of chest X-ray as a screening tool. (C) 2001 American Cancer Society.